FDA reverses 2022 marketing ban on Juul Labs' e-cigarettes, allowing sales authorization.

The U.S. Food and Drug Administration (FDA) has reversed its 2022 marketing ban on Juul Labs' e-cigarettes, allowing the company to seek authorization for its product sales once again. The FDA initially issued the marketing denial orders but later suspended them, resulting in years of legal uncertainty for the product. The decision to formally withdraw these orders represents a potential turning point in Juul's future.